5 hrs ago
Johnson & Johnson: Moving To Higher-Growth Technologies, Capitalizes On Renewed Profitability
The company is selling less profitable business units to make room for higher growth medical technologies that can drive margins and earnings up.
Fri Aug 29, 2014
Federal Computer Week
President nominates Deyo to DHS management slot
The White House plans to nominate Russell C. Deyo to fill the Department of Homeland Security's undersecretary for management position left vacant when Raphael Borras departed this past winter.
Thu Aug 28, 2014
Johnson & Johnson to seek buyer for medical device maker unit -WSJ
Johnson & Johnson plans to seek a buyer for its medical device maker business, Cordis Corp, The Wall Street Journal reported citing people familiar with the matter.
Wellness & Prevention Showcases Johnson & Johnson Official 7 Minute...
Parks Associates announced today that executives from Wellness & Prevention, Inc., a Johnson & Johnson company, will participate in the session "Population Health Management: Tracking Technology's Impact" and host a special workout session to showcase the updated Johnson & Johnson Official 7 Minute Workout App during the 2014 Connected Health ... (more)
Why Johnson & Johnson (JNJ) Stock Is Declining Today
Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.
Wed Aug 27, 2014
IBM's Jeopardy-Playing Watson Becomes Science Researcher
International Business Machines Corp. wants you to know that its Watson technology can do more than win "Jeopardy!" -- it can now help accelerate scientific research and discoveries.
Mon Aug 25, 2014
Johnson & Johnson: High Profitability, Trading Below Fair Value
Johnson & Johnson is one of the biggest healthcare companies in the world, with revenues of $74 billion and earnings of $15.6 billion in the last twelve months.
Cilag GmbH International Acquires Covagen AG
Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has acquired Covagen AG, a privately-held, biopharmaceutical company specializing in the development of multispecific protein therapeutics through the FynomAb technology platform.
Sun Aug 17, 2014
5 brands that climbed out of reputation hell
For a brand, recovering its reputation after a crisis can be a complicated business.
Fri Aug 15, 2014
National Institute for Clinical Excellence (NICE) And Johnson & Johnson Urged To End Zytiga Fiasco
Patient groups and academics have urged the National Institute for Health and Care Excellence and Johnson & Johnson unit Janssen to get back to the table following the former's rejection of Zytiga as a treatment for prostate cancer before chemotherapy.
Thu Aug 14, 2014
Johnson & Johnson: Don't Miss The Pullback Opportunity
JNJ can comfortably grow its dividend per share by 6%-7% per annum over the next few years with both free cash flow and earnings payout levels being steady.
Fri Aug 08, 2014
Anapol Schwartz Law Firm Accepting Morcellation Cancer Cases
Women and their families are urged to contact the firm immediately to protect their legal rights and discuss filing a morcellator cancer lawsuit .
Johnson & Johnson: Where Did The Bears Go? I Will Stand Alone.
Johnson & Johnson has had a nice climb in price over the last several years. The company has strong operating margins, low interest expenses, and a solid return on equity.
Thu Aug 07, 2014
Johnson & Johnson's Power Morcellator Recall Could Result In Further Pullback
Johnson & Johnson recently withdrew three laparoscopic power morcellators due to a risk of spreading cancerous tissue, following FDA's warning in April.
Dear Johnson & Johnson: Pay for Your Mistakes
Johnson & Johnson grabbed headlines this week for withdrawing from the market power morcellators, manufactured by subsidiary Ethicon, citing " uncertainty " about the "risk-benefit assessment" associated with the device's use.
UM Gets a New U.S. President
Insider Kasha Cacy today succeeds Sarah Personette as U.S. president, as Personette exits following maternity leave to become the head of global business marketing at Facebook.
Tue Aug 05, 2014
Johnson & Johnson: A Quality Dividend Company At Attractive Valuation
Johnson & Johnson is a dividend king which has paid dividends since 1944 and has managed to increase them for 52 years in a row.
Mon Aug 04, 2014
COLUMN-Healthcare: A remedy for long-term investors
The fastest-growing segment of the global population is aged 60 and over, according to the United Nations Department of Economic and Social Affairs.